These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 5804154)

  • 41. Repressor and rex product of coliphage lambda: lack of collaboration and joint controls.
    Mark KK; Szybalski W
    Mol Gen Genet; 1973; 123(2):123-34. PubMed ID: 4725965
    [No Abstract]   [Full Text] [Related]  

  • 42. The structure of genomes of individual petit particles of the bacteriophage T4D mutant E920/96/41.
    Parma DH
    Genetics; 1969 Oct; 63(2):247-61. PubMed ID: 5366211
    [No Abstract]   [Full Text] [Related]  

  • 43. Phenotypic characterization of fi- R factors determining the restriction and modification hsp II specificity.
    Hedges RW
    Mol Gen Genet; 1972; 115(3):225-33. PubMed ID: 4338039
    [No Abstract]   [Full Text] [Related]  

  • 44. The ClpXP and ClpAP proteases degrade proteins with carboxy-terminal peptide tails added by the SsrA-tagging system.
    Gottesman S; Roche E; Zhou Y; Sauer RT
    Genes Dev; 1998 May; 12(9):1338-47. PubMed ID: 9573050
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Lambda phage mutants insensitive to temperature-sensitive repressor. 3. Effects of virL, virR or virC mutation on the gene expression.
    Eshima N; Fujii S; Murotsu T; Horiuchi T
    Mol Gen Genet; 1972; 116(1):84-7. PubMed ID: 5046962
    [No Abstract]   [Full Text] [Related]  

  • 46. Evidence that pretreatment of Escherichia coli cells with N-methyl-N'-nitro-N-nitrosoguanidine enhances mutability of subsequently infecting phage lambda.
    Kondo S; Ichikawa H
    Mol Gen Genet; 1973 Nov; 126(4):319-24. PubMed ID: 4593995
    [No Abstract]   [Full Text] [Related]  

  • 47. Studies on lambda virulent mutants. II. Anti-repression and Vir-repression function of lambdavirC and lambdavirCvirR.
    Koga H; Horiuchi T
    Mol Gen Genet; 1973 Aug; 124(3):219-32. PubMed ID: 4584942
    [No Abstract]   [Full Text] [Related]  

  • 48. Studies on lambda virulent mutants. I. Isolation and characterization of revertants from lambdavirC mutant.
    Fujii S; Horiuchi T
    Mol Gen Genet; 1972; 118(3):287-94. PubMed ID: 4563168
    [No Abstract]   [Full Text] [Related]  

  • 49. A colicin-tolerant mutant of Escherichia coli with reduced levels of cyclic AMP and a strong bias towards lambda lysogeny.
    Rolfe B; Schell J; Becker A; Heip J; Onodera K; Schell-Frederick E
    Mol Gen Genet; 1973 Jan; 120(1):1-16. PubMed ID: 4346769
    [No Abstract]   [Full Text] [Related]  

  • 50. Mutations in bacteriophage lambda repressor that prevent RecA-mediated cleavage.
    Gimble FS; Sauer RT
    J Bacteriol; 1985 Apr; 162(1):147-54. PubMed ID: 3156848
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Mutations in an integration host factor-binding site: effect on lambda site-specific recombination and regulatory implications.
    Thompson JF; Waechter-Brulla D; Gumport RI; Gardner JF; Moitoso de Vargas L; Landy A
    J Bacteriol; 1986 Dec; 168(3):1343-51. PubMed ID: 2946666
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Use of lac fusions to measure in vivo regulation of expression of Escherichia coli proton-translocating ATPase (unc) genes.
    Angov E; Brusilow WS
    J Bacteriol; 1988 Jan; 170(1):459-62. PubMed ID: 2891682
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Use of lacZ fusions to measure in vivo expression of the first three genes of the Escherichia coli unc operon.
    Solomon KA; Hsu DK; Brusilow WS
    J Bacteriol; 1989 Jun; 171(6):3039-45. PubMed ID: 2524469
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A pleiotropic regulatory mutation in lambda bacteriophage.
    Honigman A; Oppenheim A; Oppenheim AB
    Mol Gen Genet; 1975; 138(2):85-111. PubMed ID: 1196300
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Insertion of bacteriophage lambda into the deo operon of Escherichia coli K-12 and isolation of plaque-forming lambdadeo+ transducing bacteriophages.
    Buxton RS; Hammer-Jespersen K; Hansen TD
    J Bacteriol; 1978 Nov; 136(2):668-81. PubMed ID: 361716
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Isolation and characterization of lambda pleu bacteriophages.
    Davis MG; Calvo JM
    J Bacteriol; 1977 Feb; 129(2):1078-90. PubMed ID: 320178
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Aberrant immunity behaviour of hybrid lambda imm21 phages containing the DNA of ColE1-type plasmids.
    Windass JD; Brammar WJ
    Mol Gen Genet; 1979; 172(3):329-37. PubMed ID: 45615
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Mechanism of lambda-c17cI virulence.
    Sly WS; Rabideau K
    J Mol Biol; 1969 Jun; 42(3):385-400. PubMed ID: 5804154
    [No Abstract]   [Full Text] [Related]  

  • 59. Studies on partially virulent mutants of lambda bacteriophage. II. The mechanism of overcoming repression.
    Oppenheim AB; Salomon D
    Mol Gen Genet; 1972; 115(2):101-14. PubMed ID: 4554471
    [No Abstract]   [Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.